A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)

Target PharmaSolutions, Inc.

Summary

TARGET-NASH is a longitudinal observational cohort study of patients being managed for NASH and related conditions across the entire spectrum NAFLD in usual clinical practice. TARGET-NASH is a research registry of patients with NAFL or NASH within academic and community real-world practices maintained in order to assess the safety and effectiveness of current and future therapies.

Eligibility

Age range: 2+ years
Sex: All
Healthy volunteers: No

Detailed criteria

Inclusion Criteria: 1\. Adults and children (age 2 or older) being managed or treated for nonalcoholic fatty liver disease. Diagnosis is based on the clinical judgement of the care provider. Exclusion Criteria: 1\. Inability to provide informed assent/consent.

Locations (74)

Banner University Medical Center - Phoenix Transplant Center and Advanced Liver Clinic
Phoenix, Arizona
Stanford University
Palo Alto, California
California Liver Research Institute
Pasadena, California
University of California, Davis
Sacramento, California
Silicon Valley Research Institute
San Jose, California
University of Colorado Anschutz Medical Campus
Aurora, Colorado